MIF antibody
Principal name
MIF antibody
Alternative names for MIF antibody
Macrophage migration inhibitory factor, Phenylpyruvate tautomerase, Glycosylation-inhibiting factor, GLIF, MMIF
SwissProt ID
P14174 (Human), P30904 (Rat), P34884 (Mouse), P80177 (Bovin), P80928 (Pig), Q1ZZU7 (Sheep)
Ncbi ID
NP_002406.1, NP_112313.1, 9606, NP_002406, NP_034928, NP_034928.1, NM_010798, NM_031051
Available reactivities
Available hosts
Available applications
Immunocytochemistry/Immunofluorescence (ICC/IF), Flow Cytometry (F), Enzyme Immunoassay (E), Western blot / Immunoblot (WB), Paraffin Sections (P), Immunoprecipitation (IP), ELISA (detection) (E(detection)), EPair for Elisa (EPair)
Background of MIF antibody
Cytokines play an important role in inflammation and immunity. Macrophage migration inhibitory factor (MIF) was one of the first cytokine activities described and is a proinflammatory cytokine that plays an important role in systemic inflammatory events. MIF's cytokine activity was initially described as a T cell-derived factor that inhibited the random migration of macrophages, hence its name. Since it was cloned and expressed in pure form, MIF's activities have been established to play many roles in development and various disease states. For example, MIF is released from macrophages and T cells in response to physiological concentrations of glucocorticoids. The secreted MIF counterregulates the immunosuppressive effects of steroids on immune cell activation and cytokine production. In in vitro experiments MIF is significantly upregulated by the stimulation of lipopolysaccharide (LPS) using 10 pg/ml to 10 ng/ml of LPS and reaches the maximum 12 h after the stimulation. MIF also prevents cleavage of Bax into an 18-kDa active fragment, and, consequently, reduces activation of the critical effector caspase 3, suggesting that MIF inhibits apoptosis pathways proximal to mitochondria activation and is therefore a survival factor. And, MIF is also known to exhibit enzymatic activities. A pathologic role for MIF has been described in many conditions including arthritis, asthma, and inflammatory bowel disease, and may also play a role in the control of cell growth in certain cancers. Consequently MIF is suggested to be a potential therapeutic target for human diseases.
General readings
Church TS, Willis MS, Priest EL, Lamonte MJ, Earnest CP, Wilkinson WJ, Wilson DA, Giroir BP. Obesity, macrophage migration inhibitory factor, and weight loss. Int J Obes Relat Metab Disord. 2005 Mar 29

Lane 1: Jurkat cell lysate.
Lane 2: THP-1 cell lysate.
Lane 3: HeLa cell lysate.
Lane 4: U937 cell lysate.















Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA303028 | MIF (C-term) antibody |
||||||
| Goat Polyclonal Antibody against MIF | |||||||
![]() |
Goat | Aff - Purified | Hu, Ms, Rt | E, WB |
0.1 mg /
€360.00
|
||
| OriGene Technologies, Inc. | |||||||
+1 additional image |
|||||||
| TA319100 | MIF antibody |
||||||
| Rabbit polyclonal anti-macrophage migration inhibitory factor (MIF) antibody | |||||||
![]() |
Rabbit | Purified | Ms, Rt | IP, WB |
0.1 mg /
€355.00
|
||
| OriGene Technologies, Inc. | |||||||
| TA319159 | MIF antibody |
||||||
| Chicken polyclonal anti-MIF antibody | |||||||
![]() |
Chicken | Purified | Hu | E, WB |
0.5 mg /
€590.00
|
||
| OriGene Technologies, Inc. | |||||||
| TA327040 | MIF antibody |
||||||
| Rabbit anti-MIF Polyclonal Antibody | |||||||
![]() |
Rabbit | IgG | Purified | Hu, Ms, Rt |
0.1 mg /
€335.00
|
||
| OriGene Technologies, Inc. | |||||||
+1 additional image |
|||||||
| AP08883PU-N | MIF (103-115) antibody |
||||||
![]() |
Goat | IgG | Aff - Purified | Elephant, Hu, Mky, Platypus | E, P, WB |
50 µg /
€425.00
|
|
| OriGene Technologies GmbH | |||||||
+1 additional image |
|||||||
| AP23265PU-N | MIF (C-term) antibody |
||||||
![]() |
Rabbit | IgG | Aff - Purified | Hu, Ms, Rt | P, WB |
0.1 mg /
€390.00
|
|
| OriGene Technologies GmbH | |||||||
+1 additional image |
|||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP305106 | MIF |
||||
| Recombinant protein of human macrophage migration inhibitory factor (glycosylation-inhibiting factor) (MIF) | |||||
![]() |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
| TP723300 | MIF |
||||
| Purified recombinant protein of Human macrophage migration inhibitory factor (glycosylation-inhibiting factor) (MIF). | |||||
![]() |
Human | > 95 % Preparation: . Purity Detail: >95% as determined by SDS-PAGE and Coomassie blue staining. |
25 µg /
€230.00
|
||
| OriGene Technologies, Inc. | |||||
| SA6053 | MIF (1-115, His-tag) |
||||
![]() |
Human | Purified | > 95 % by SDS-PAGE | E. coli |
0.1 mg /
€250.00
|
| OriGene Technologies GmbH | |||||
+1 additional image |
|||||
| SA6053X | MIF (1-115, His-tag) |
||||
![]() |
Human | Purified | > 95 % by SDS-PAGE | E. coli |
0.5 mg /
€600.00
|
| OriGene Technologies GmbH | |||||
+1 additional image |
|||||
| PR27042-5 | MIF |
||||
![]() |
Human | Purified | > 95 % | E. coli |
5 µg /
€190.00
|
| Neuromics Antibodies | |||||
| PR27042-25 | MIF |
||||
![]() |
Human | Purified | > 95 % | E. coli |
25 µg /
€290.00
|
| Neuromics Antibodies | |||||
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR200478L2V | Lenti ORF particles, Mif (GFP-tagged) - Mouse macrophage migration inhibitory factor (Mif), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| MR200478L1V | Lenti ORF particles, Mif (Myc-DDK-tagged) - Mouse macrophage migration inhibitory factor (Mif), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||
Rat Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RR212389L2V | Lenti ORF particles, Mif (GFP-tagged ORF) - Rat macrophage migration inhibitory factor (Mif), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| RR212389L1V | Lenti ORF particles, Mif (Myc-DDK-tagged ORF) - Rat macrophage migration inhibitory factor (Mif), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||






















+1 additional image








